Ensign Peak Advisors, Inc - ARCUTIS BIOTHERAPEUTICS INC ownership

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 79 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Ensign Peak Advisors, Inc ownership history of ARCUTIS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,386,565
-44.7%
826,095
-0.8%
0.01%
-43.8%
Q2 2023$7,934,106
+48.3%
832,540
+71.2%
0.02%
+33.3%
Q1 2023$5,348,640
-25.4%
486,240
+0.3%
0.01%
-25.0%
Q4 2022$7,171,370
-23.3%
484,552
-1.0%
0.02%
-30.4%
Q3 2022$9,352,000
+15.5%
489,345
+28.8%
0.02%
+21.1%
Q2 2022$8,095,000
-15.2%
379,895
-23.3%
0.02%0.0%
Q1 2022$9,544,000
+9.7%
495,450
+18.1%
0.02%
+11.8%
Q4 2021$8,704,000
-6.6%
419,674
+7.6%
0.02%
-10.5%
Q3 2021$9,316,000
-14.1%
389,938
-1.8%
0.02%
-13.6%
Q2 2021$10,840,000
+118.8%
397,216
+132.0%
0.02%
+100.0%
Q1 2021$4,954,000
+356.2%
171,203
+343.5%
0.01%
+450.0%
Q4 2020$1,086,000
+69.4%
38,604
+76.5%
0.00%0.0%
Q3 2020$641,000
+182.4%
21,876
+191.7%
0.00%
+100.0%
Q2 2020$227,000
+1.3%
7,5000.0%0.00%0.0%
Q1 2020$224,0007,5000.00%
Other shareholders
ARCUTIS BIOTHERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 8,684,232$46,113,2723.06%
Pivotal bioVenture Partners Investment Advisor LLC 1,105,309$5,869,1912.34%
Bain Capital Life Sciences Investors, LLC 3,000,000$15,930,0001.78%
Sio Capital Management, LLC 635,969$3,376,9951.04%
Rubric Capital Management LP 5,034,530$26,733,3541.00%
Tejara Capital Ltd 309,179$1,641,7400.93%
AlphaCentric Advisors LLC 165,000$876,1500.50%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,135,227$6,028,0550.33%
Orbimed Advisors 1,914,479$10,165,8830.22%
Two Seas Capital LP 164,807$875,1250.18%
View complete list of ARCUTIS BIOTHERAPEUTICS INC shareholders